Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1991 1
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

2 results
Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Suppressive effect of delta-9-tetrahydrocannabinol on herpes simplex virus infectivity in vitro.
Lancz G, Specter S, Brown HK. Lancz G, et al. Proc Soc Exp Biol Med. 1991 Apr;196(4):401-4. doi: 10.3181/00379727-196-43206. Proc Soc Exp Biol Med. 1991. PMID: 1848937
Delta-9-Tetrahydrocannabinol (THC) was found to reduce the infectivity of herpes simplex virus and was without effect against adenovirus type 2 or poliovirus. ...Thus, the data suggest that THC preferentially reduces the
Delta-9-Tetrahydrocannabinol (THC) was found to reduce the infectivity of herpes simplex virus
Delta-9-tetrahydrocannabinol inhibits the splenocyte proliferative response to herpes simplex virus type 2.
Cabral GA, McNerney PJ, Mishkin EM. Cabral GA, et al. Immunopharmacol Immunotoxicol. 1987;9(2-3):361-70. doi: 10.3109/08923978709035219. Immunopharmacol Immunotoxicol. 1987. PMID: 2830329
The present investigation was undertaken to determine the effect of in vivo Delta-9-tetrahydrocannabinol (Delta-9-THC) treatment on immune responsiveness to secondary exposure to herpes simplex virus type 2 (HSV2) ant …
The present investigation was undertaken to determine the effect of in vivo Delta-9-tetrahydrocannabinol (Del